LOXAPINE SUCCINATE Drug Patent Profile
✉ Email this page to a colleague
When do Loxapine Succinate patents expire, and when can generic versions of Loxapine Succinate launch?
Loxapine Succinate is a drug marketed by Elite Labs Inc, Lannett Co Inc, Rising, and Watson Labs. and is included in seven NDAs.
The generic ingredient in LOXAPINE SUCCINATE is loxapine succinate. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the loxapine succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Loxapine Succinate
A generic version of LOXAPINE SUCCINATE was approved as loxapine succinate by WATSON LABS on June 15th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOXAPINE SUCCINATE?
- What are the global sales for LOXAPINE SUCCINATE?
- What is Average Wholesale Price for LOXAPINE SUCCINATE?
Summary for LOXAPINE SUCCINATE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 7 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 88 |
| Clinical Trials: | 2 |
| Patent Applications: | 1,231 |
| Drug Prices: | Drug price information for LOXAPINE SUCCINATE |
| DailyMed Link: | LOXAPINE SUCCINATE at DailyMed |
Recent Clinical Trials for LOXAPINE SUCCINATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Witten/Herdecke | Phase 2 |
| Mylan Pharmaceuticals | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for LOXAPINE SUCCINATE
US Patents and Regulatory Information for LOXAPINE SUCCINATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elite Labs Inc | LOXAPINE SUCCINATE | loxapine succinate | CAPSULE;ORAL | 076868-001 | Aug 4, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Lannett Co Inc | LOXAPINE SUCCINATE | loxapine succinate | CAPSULE;ORAL | 090695-003 | Sep 26, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Elite Labs Inc | LOXAPINE SUCCINATE | loxapine succinate | CAPSULE;ORAL | 076868-004 | Aug 4, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rising | LOXAPINE SUCCINATE | loxapine succinate | CAPSULE;ORAL | 076762-004 | Nov 1, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lannett Co Inc | LOXAPINE SUCCINATE | loxapine succinate | CAPSULE;ORAL | 090695-004 | Sep 26, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | LOXAPINE SUCCINATE | loxapine succinate | CAPSULE;ORAL | 072062-001 | Jun 15, 1988 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | LOXAPINE SUCCINATE | loxapine succinate | CAPSULE;ORAL | 072205-001 | Jun 15, 1988 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
